Lookback: How Smallcaps Outpaced Largecaps in the 2024,2026 Cycle

Eighteen months of smallcap supremacy that flipped the post-2023 largecap script, and the policy plus flow stack that paid for it.

The cleanest way to remember the August 2024 to January 2026 stretch on Dalal Street was as the period when the conventional wisdom about Indian equities, that largecaps were the only honest place to park rupees after the 2024 election volatility, got systematically dismantled. The BSE Smallcap index closed 30 January 2026 with a cumulative gain of roughly 38% from its 8 August 2024 base, while the Sensex managed a comparatively pedestrian 12% over the same window. That gap, 26 percentage points of relative outperformance, was not delivered in a straight line and it was not delivered without two genuine drawdowns. It was, however, delivered with enough consistency that by Q3 of the cycle the smallcap-to-largecap ratio chart had become the single most-shared screenshot in dealer rooms from BKC to Connaught Place.

I want to walk through what actually drove that divergence, because the lazy explanation, retail euphoria plus liquidity, missed at least three structural forces and one regulatory shift that mattered more than the flow noise. The cycle was not a 2017-style smallcap mania. It rhymed with 2003 to 2005 far more than with 2017 to 2018, and the difference showed up in earnings dispersion and the absence of a true blowoff top by January 2026.

What triggered the regime change

The pivot point was not the August 2024 print itself. The August low on the BSE Smallcap was a function of the late-July correction that had spilled over from largecap profit-booking after the Budget tax tweaks. The real trigger arrived in October and November 2024, when three things landed almost simultaneously.

First, the SEBI working paper on domestic mutual fund concentration risk, which had been circulating since mid-2024, produced concrete guidance that pushed fund houses to broaden their portfolio universe. The practical effect, visible in the AMFI monthly disclosures through Q4 2024, was that smallcap and midcap schemes received a disproportionate share of net new SIP inflows. The SIP book itself crossed the ₹25,000 crore monthly run-rate by late 2024 according to AMFI data, and a meaningful slice of that incremental flow was steered toward funds with smaller-cap mandates.

Second, the RBI's stance shift through the December 2024 policy meeting, where the central bank softened its forward guidance after holding repo steady, opened a real conversation about a 2025 cutting cycle. Smallcaps, with their higher leverage and higher domestic-revenue tilt, were always going to be the first to price in lower funding costs. By the February 2025 cut, the smallcap index had already moved well ahead of the curve.

Third, and this part rarely got captured in the talking-head circuit, the FII selling that had pressured largecaps in October 2024 simply did not extend down the cap curve. NSDL data through that quarter showed that foreign outflows were concentrated in Nifty 50 names where the foreign ownership stack was crowded. Smallcaps, with their thin foreign float, were structurally insulated from that particular pain. DII buying, on the other hand, was indiscriminate, and it landed proportionally harder on the smaller pond.

Caption: The weekly view captures the three distinct legs of the cycle, the slow grind through Q4 2024, the acceleration after the February 2025 RBI cut, and the consolidation range through Q4 2025.

What sustained it

Triggers are cheap. Plenty of sector rotations have started on policy tailwinds and died inside six months because the earnings did not show up. The 2024 to 2026 smallcap cycle survived because the earnings did show up, and they showed up in the right places.

Through the three quarterly seasons that anchored the cycle, Q3 FY25, Q4 FY25, and Q1 FY26, the aggregate revenue growth for the BSE Smallcap basket comfortably outpaced the largecap aggregate. The dispersion was sharper than headline averages suggested. Capital goods, defence ancillaries, specialty chemicals, and the smaller private-sector banks delivered earnings beats that surprised even the brokerages tracking them. Meanwhile the IT services largecaps were stuck in their well-documented growth funk through most of 2025, and the FMCG majors continued to wrestle with rural recovery that arrived later and more unevenly than the consensus had assumed.

The earnings dispersion was the real story. If the cycle had been a pure liquidity inflation, the breadth would have looked uniform, every smallcap rising on a rising tide. Instead, what the screening filters picked up through 2025 was a bifurcation. Roughly the top quartile of the smallcap universe, by trailing earnings growth, captured the lion's share of the index returns. The bottom quartile, dominated by the older small-cap names that had survived but not thrived, was actually flat to negative in many months. That bifurcation was healthy. It meant fundamental investors had reasons to participate rather than chase, and it meant the cycle had a real anchor beyond the SIP firehose.

Brokerage behaviour through the window was informative on its own. The major domestic houses, Kotak, ICICI, Motilal, started the August 2024 period with their model portfolios overweight largecaps and cautious on smallcap valuations. The shift was gradual. By Q2 of 2025 most desks had quietly upgraded their smallcap exposure in their recommended allocations, and by mid-2025 it was hard to find a published model portfolio that did not carry an explicit smallcap or midcap overweight. The chasing-the-trend pattern in sell-side recommendations was textbook, and it was a reasonable mid-cycle marker that the move had room left when retail and DIIs were still net buyers but the brokerages were only now arriving.

Leadership rotation inside the index

The cleanest way to understand a sector cycle is to track which names actually led. The smallcap leadership through this window was not static. It rotated through at least three distinct phases.

Phase one, roughly August 2024 through January 2025, was led by defence ancillaries and railway-PSU adjacencies. These names had been beaten down through mid-2024 after the runaway 2023 PSU rally lost steam. The order-book rebuilds through Q3 FY25, combined with renewed Budget visibility on capex, gave the basket a second wind. Several names in this cluster doubled from their August 2024 lows by late January 2025 according to NSE bhavcopy data, though I want to be careful not to anchor on any single quote without the bhavcopy in front of me.

Phase two, February through July 2025, rotated toward specialty chemicals and select capital goods. The China-plus-one tailwind, dormant through most of 2024, came back into sell-side notes through Q1 2025 as European customers reportedly accelerated supplier diversification. Specialty chemicals, having spent 2023 and most of 2024 in a margin-squeeze cycle, started reporting sequential margin recovery from the March 2025 quarter onward. That margin recovery, combined with operating leverage, was rocket fuel for the smaller listed names in the pocket.

Phase three, August 2025 onward through the January 2026 close, was where it got interesting. Leadership broadened into smaller private banks, NBFCs with niche lending books, and a handful of consumer-discretionary names that played the rural-recovery thesis. This third phase was the one where the cycle started feeling more crowded. Newer NFOs in smallcap and multicap categories accelerated, and the AMFI disclosures through Q4 2025 showed several houses temporarily suspending lumpsum inflows into their smallcap schemes citing deployment difficulty. That is the kind of detail that, in hindsight, marked a fairly late-cycle moment. Funds that cannot deploy fast enough are signalling that the supply of investable names at reasonable valuations is thinning.

Caption: The daily chart shows the two genuine drawdowns of the cycle, the roughly 9% pullback in March 2025 ahead of the FY26 Budget, and the sharper 12% correction in September to October 2025 driven by FII selling and a brief global risk-off.

Cross-sector comparison: who lagged, who led

The smallcap outperformance did not happen in a vacuum. The same period featured a quiet largecap story that the headline Sensex number obscured. Within the Sensex itself, the dispersion was meaningful. The private-sector financials, after years of underperformance versus the broader Nifty, finally had a constructive 2025 as net interest margin compression slowed and credit growth re-accelerated through the cut cycle. IT services lagged badly, with the largecap IT pack closing the cycle effectively flat after accounting for the Q4 2024 selldown. FMCG was mediocre. Energy was a mixed bag, with the Reliance complex anchoring the index and the OMCs swinging on crude.

If you zoomed out and benchmarked against Asian peers, the Indian smallcap basket through this window was one of the better-performing equity buckets globally. Korean smallcaps had a separate story driven by their domestic value-up programme. Taiwanese smallcaps were tied to the semiconductor capex cycle. Chinese A-share smallcaps had their own policy-driven move through late 2024 into 2025. The Indian story stood out because the drivers were almost entirely domestic, almost entirely policy and flow plus genuine earnings, with very little dependence on the global-cycle hand-me-downs that usually shape Asian small-cap performance.

The point worth dwelling on is that the largecap underperformance against smallcaps was not a function of largecap collapse. The Sensex's 12% over eighteen months, annualised, was a perfectly respectable return. The largecaps held their own. They were simply lapped by a smaller, hungrier, more domestically-flavoured basket that had every tailwind and almost no headwind for most of the period.

Historical analog

The most useful prior cycle to compare this against was 2003 to 2005, not 2017. The 2017 to 2018 smallcap rally, which culminated in the brutal February 2018 reset, was characterised by widespread valuation excess across the entire cap curve, weak underlying earnings, and a flow-driven runup that priced in growth that never arrived. The aftermath, the 2018 to 2019 smallcap drawdown, took most of the index back near its starting point and forced a long convalescence.

2003 to 2005, by contrast, was a cycle anchored by genuine capex-driven earnings growth, a young domestic mutual fund industry that was learning to deploy at scale, and a macro backdrop of falling real rates. The 2024 to 2026 cycle echoed that earlier pattern more than it echoed 2017. The earnings were broadly real. The flows were broadly sticky, with the SIP book providing a baseline that was structurally different from the lump-sum-driven 2017 boom. And the macro tailwinds, a rate-cutting cycle that arrived gradually rather than aggressively, gave the cycle the kind of slow-burn quality that allowed valuations to stretch without snapping.

That said, by the January 2026 close, the average smallcap forward earnings multiple sat at a clear premium to its ten-year median based on the brokerage commentary that filtered through the consensus channels. The premium was defensible if earnings continued to compound at the pace of the prior six quarters. It was not defensible if earnings reverted to long-run averages. The setup, in that sense, was familiar to anyone who had lived through the 2005 to 2007 segment of the prior cycle. Late-cycle, valuation-stretched, but with enough fundamental momentum to keep going for longer than the bears expected.

The intraday signature

One of the more telling features of late-cycle smallcap behaviour was the intraday pattern that emerged through Q4 2025. The opening half-hour, historically the most volatile window for smallcaps because of overnight news absorption and gap fills, started showing a consistent buy-on-dip pattern. Sell-side desks reported that institutional buy programmes were leaning into morning weakness rather than fading rallies into the afternoon. That microstructure tell, which I want to flag but not over-read, was consistent with a market where the marginal large buyer was a domestic mutual fund deploying SIP money on a near-mechanical schedule.

Caption: The 30 January 2026 session shows the buy-the-dip signature that became routine through late 2025, with morning weakness absorbed and a steady afternoon grind into the close.

That microstructure was not bulletproof. The September to October 2025 drawdown demonstrated that when FII selling intensified and global risk-off coincided with a brief stretch of weak DII flows, smallcaps gave back roughly 12% from peak in three weeks. The mechanical SIP support was a floor, not an insurance policy. The drawdown was bought aggressively, and the index recovered the lost ground by mid-November, but the speed of the September break was a reminder that liquidity in smallcaps is asymmetric. The bid disappears faster than the offer in stress conditions.

The valuation question at the end of the period

By 30 January 2026, the cleanest way to characterise the smallcap basket was that it had moved from cheap to fair to expensive, in that order, across the eighteen-month window. The August 2024 starting point had been, by most reasonable measures, a fair-to-cheap level relative to the basket's own history. The early 2025 rally took valuations to fair. The summer of 2025 took them to expensive on a forward multiple basis but still arguably justified by earnings momentum. The Q4 2025 push extended valuations into a range where the margin for error had visibly compressed.

The market-cap-to-GDP ratio for the broader Indian equity market sat in record territory through this window, with the smallcap component contributing a meaningfully larger share than at any prior comparable point in the last fifteen years. That data point, regularly referenced in the Buffett-indicator commentary through late 2025, was a useful sanity check. It did not call a top. It did, however, mean that any incremental positive surprise would have to do more work to push valuations higher, while any negative surprise would have a larger gap to close.

Reading the policy stack at period-end

The regulatory environment at the January 2026 close was not the same as the regulatory environment at the August 2024 start. SEBI, through 2025, had introduced a series of disclosures and stress-test requirements for mutual fund smallcap and midcap schemes that materially changed how the largest asset managers thought about deployment. The half-yearly stress-test disclosures forced houses to publish their estimated liquidity-to-redemption profiles, and those disclosures, viewed in aggregate, suggested that the largest smallcap schemes had become structurally more cautious about lumpsum inflows.

That caution showed up in the deployment patterns of the bigger funds, which started running noticeably higher cash levels through Q4 2025. Cash drag, on a rising market, was a real opportunity cost. The funds accepted it because the alternative, forced selling into thin order books during a redemption shock, was a worse problem to have. The point worth carrying forward was that the regulatory frame in early 2026 was substantially more risk-aware than it had been at the cycle start.

The verdict

Looking back at the August 2024 to January 2026 window, the smallcap-versus-largecap divergence was driven by a stack of supports that mostly held. Earnings were real. Flows were sticky. Policy was constructive. Foreign selling did not extend down the cap curve. Brokerage upgrades chased the move rather than leading it.

At the same time, the period closed with valuations stretched, fund houses running defensive cash, intraday microstructure looking late-cycle, and the SIP book having to do more work to absorb new deployment. The cycle was not over at the January 2026 close. The case that the easy money in the trade had already been made, however, was hard to argue against.

VERDICT Stance: NEUTRAL on smallcaps versus largecaps at the 30 January 2026 close, with a tilt toward largecaps over a 3mo horizon. Horizon: 3mo. Rationale: The smallcap outperformance through 2024 to 2026 was structurally well-supported, but the period closed with valuations stretched, fund cash levels rising, and the marginal incremental tailwind harder to identify. Largecaps, having underperformed for eighteen months, looked relatively better-positioned for the next leg, particularly in financials and select energy. The smallcap basket needed an earnings beat in Q4 FY26 to justify the prevailing multiple. Without that beat, a period of sideways digestion was the higher-probability path.

Aditya Sharma X: @Declan142 LinkedIn: linkedin.com/in/aditya-sharma-119ab4324